Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 44 | 2024 | 1605 | 6.020 |
Why?
|
Aldosterone | 15 | 2023 | 881 | 3.130 |
Why?
|
Pulmonary Artery | 21 | 2024 | 1946 | 2.260 |
Why?
|
Glucosephosphate Dehydrogenase | 16 | 2020 | 209 | 1.900 |
Why?
|
Vascular Diseases | 10 | 2022 | 1162 | 1.620 |
Why?
|
Endothelium, Vascular | 22 | 2017 | 4427 | 1.460 |
Why?
|
Muscle, Smooth, Vascular | 15 | 2024 | 1493 | 1.430 |
Why?
|
Ventricular Dysfunction, Right | 10 | 2024 | 646 | 1.160 |
Why?
|
Oxidative Stress | 20 | 2016 | 3139 | 1.150 |
Why?
|
Ventricular Function, Right | 8 | 2024 | 629 | 1.130 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2022 | 1724 | 1.020 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 6 | 2021 | 131 | 0.990 |
Why?
|
Pulmonary Circulation | 5 | 2022 | 745 | 0.960 |
Why?
|
Hemodynamics | 13 | 2024 | 4194 | 0.950 |
Why?
|
Spironolactone | 8 | 2016 | 415 | 0.930 |
Why?
|
Nitric Oxide | 12 | 2012 | 2146 | 0.870 |
Why?
|
Neointima | 2 | 2014 | 133 | 0.860 |
Why?
|
Myocytes, Smooth Muscle | 8 | 2024 | 702 | 0.860 |
Why?
|
Hyperaldosteronism | 4 | 2023 | 252 | 0.790 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15662 | 0.780 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 157 | 0.760 |
Why?
|
Vasoconstriction | 3 | 2022 | 592 | 0.740 |
Why?
|
Glutathione Peroxidase | 8 | 2011 | 259 | 0.720 |
Why?
|
Blood Vessels | 4 | 2016 | 1110 | 0.720 |
Why?
|
Remote Sensing Technology | 1 | 2021 | 93 | 0.710 |
Why?
|
Coronary Angiography | 9 | 2024 | 4541 | 0.690 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2012 | 344 | 0.690 |
Why?
|
Receptors, Mineralocorticoid | 4 | 2016 | 167 | 0.690 |
Why?
|
Coronary Vessels | 8 | 2024 | 3124 | 0.690 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2021 | 241 | 0.680 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 6 | 2024 | 325 | 0.680 |
Why?
|
Radiation Protection | 1 | 2023 | 428 | 0.670 |
Why?
|
Hypertension | 10 | 2024 | 8616 | 0.670 |
Why?
|
Heart Failure | 11 | 2024 | 11879 | 0.670 |
Why?
|
Reactive Oxygen Species | 17 | 2015 | 2149 | 0.650 |
Why?
|
Antioxidants | 11 | 2016 | 1673 | 0.640 |
Why?
|
Calcinosis | 5 | 2020 | 1481 | 0.630 |
Why?
|
Coronary Artery Disease | 10 | 2024 | 6568 | 0.620 |
Why?
|
Plague | 1 | 2018 | 20 | 0.600 |
Why?
|
Oxidants | 4 | 2013 | 168 | 0.590 |
Why?
|
Endothelial Cells | 9 | 2018 | 3589 | 0.580 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 8 | 2012 | 94 | 0.570 |
Why?
|
Models, Cardiovascular | 3 | 2024 | 981 | 0.540 |
Why?
|
MicroRNAs | 3 | 2020 | 3803 | 0.540 |
Why?
|
Health Status Indicators | 1 | 2021 | 969 | 0.520 |
Why?
|
Humans | 137 | 2024 | 768166 | 0.510 |
Why?
|
Vascular Resistance | 5 | 2024 | 939 | 0.510 |
Why?
|
Lung | 8 | 2024 | 10099 | 0.510 |
Why?
|
Autonomic Pathways | 1 | 2015 | 31 | 0.510 |
Why?
|
Antigens, CD34 | 2 | 2018 | 657 | 0.500 |
Why?
|
Oxidoreductases | 2 | 2009 | 410 | 0.490 |
Why?
|
Sex Characteristics | 2 | 2021 | 2650 | 0.490 |
Why?
|
Lung Diseases | 4 | 2024 | 1944 | 0.490 |
Why?
|
Ventricular Remodeling | 6 | 2024 | 1281 | 0.480 |
Why?
|
Endomyocardial Fibrosis | 1 | 2014 | 41 | 0.470 |
Why?
|
Nitric Oxide Synthase Type III | 4 | 2012 | 706 | 0.470 |
Why?
|
Pulmonary Fibrosis | 2 | 2019 | 506 | 0.470 |
Why?
|
Denervation | 1 | 2015 | 265 | 0.470 |
Why?
|
Drug-Eluting Stents | 3 | 2017 | 681 | 0.460 |
Why?
|
Lipocalins | 1 | 2015 | 161 | 0.460 |
Why?
|
Acute-Phase Proteins | 1 | 2015 | 252 | 0.450 |
Why?
|
Pulmonary Wedge Pressure | 5 | 2024 | 277 | 0.450 |
Why?
|
Monocrotaline | 1 | 2013 | 26 | 0.440 |
Why?
|
Phenylpropionates | 1 | 2013 | 34 | 0.430 |
Why?
|
Pulmonary Veins | 2 | 2021 | 758 | 0.430 |
Why?
|
Stem Cells | 4 | 2018 | 3537 | 0.430 |
Why?
|
Diphosphates | 1 | 2013 | 89 | 0.420 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2006 | 577 | 0.420 |
Why?
|
Cardiovascular System | 1 | 2020 | 841 | 0.410 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2024 | 346 | 0.410 |
Why?
|
Connective Tissue Diseases | 1 | 2015 | 285 | 0.410 |
Why?
|
Heart Ventricles | 7 | 2024 | 3841 | 0.400 |
Why?
|
Aorta | 6 | 2020 | 2045 | 0.400 |
Why?
|
Receptor, Endothelin B | 1 | 2012 | 46 | 0.400 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 375 | 0.390 |
Why?
|
Cardiac Output, Low | 1 | 2012 | 192 | 0.390 |
Why?
|
Coronary Aneurysm | 1 | 2014 | 234 | 0.390 |
Why?
|
Vasodilation | 5 | 2016 | 967 | 0.380 |
Why?
|
Pyridazines | 1 | 2013 | 203 | 0.380 |
Why?
|
Metabolomics | 1 | 2021 | 1674 | 0.370 |
Why?
|
Neurotransmitter Agents | 1 | 2015 | 663 | 0.370 |
Why?
|
Progeria | 1 | 2013 | 188 | 0.370 |
Why?
|
Exercise Tolerance | 5 | 2024 | 846 | 0.370 |
Why?
|
Systems Biology | 2 | 2018 | 482 | 0.370 |
Why?
|
Oncogene Proteins | 1 | 2015 | 717 | 0.370 |
Why?
|
Research Report | 3 | 2021 | 369 | 0.360 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2010 | 29 | 0.360 |
Why?
|
Biological Evolution | 1 | 2016 | 1076 | 0.350 |
Why?
|
Delayed Diagnosis | 1 | 2014 | 467 | 0.350 |
Why?
|
Signal Transduction | 11 | 2024 | 23645 | 0.350 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 840 | 0.340 |
Why?
|
Up-Regulation | 4 | 2020 | 4146 | 0.340 |
Why?
|
Diuretics | 1 | 2013 | 614 | 0.340 |
Why?
|
Cells, Cultured | 18 | 2020 | 19015 | 0.340 |
Why?
|
Oxidation-Reduction | 11 | 2013 | 2227 | 0.340 |
Why?
|
Acute Coronary Syndrome | 2 | 2014 | 2194 | 0.340 |
Why?
|
Health Behavior | 1 | 2021 | 2650 | 0.330 |
Why?
|
Nanoparticles | 1 | 2021 | 1985 | 0.330 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2014 | 539 | 0.330 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2010 | 174 | 0.330 |
Why?
|
Calcium | 2 | 2022 | 5792 | 0.330 |
Why?
|
Vasodilator Agents | 4 | 2020 | 990 | 0.330 |
Why?
|
Microcirculation | 1 | 2014 | 1281 | 0.320 |
Why?
|
Computational Biology | 3 | 2021 | 3568 | 0.320 |
Why?
|
Animals | 57 | 2024 | 169246 | 0.320 |
Why?
|
Free Radicals | 1 | 2009 | 238 | 0.320 |
Why?
|
Phosphoproteins | 2 | 2018 | 2451 | 0.320 |
Why?
|
Coronary Stenosis | 3 | 2024 | 802 | 0.320 |
Why?
|
Serpins | 1 | 2010 | 246 | 0.320 |
Why?
|
Health Status | 2 | 2021 | 4091 | 0.320 |
Why?
|
Thrombosis | 6 | 2020 | 2957 | 0.320 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1304 | 0.310 |
Why?
|
Xanthine Oxidase | 2 | 2006 | 69 | 0.310 |
Why?
|
Receptors, Glucocorticoid | 1 | 2010 | 309 | 0.310 |
Why?
|
Computer Simulation | 3 | 2021 | 6283 | 0.300 |
Why?
|
Phenotype | 9 | 2023 | 16726 | 0.300 |
Why?
|
Guanylate Cyclase | 1 | 2009 | 206 | 0.300 |
Why?
|
Coronary Circulation | 1 | 2014 | 1617 | 0.300 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 11928 | 0.300 |
Why?
|
Antihypertensive Agents | 2 | 2018 | 2029 | 0.290 |
Why?
|
Disulfides | 2 | 2009 | 466 | 0.290 |
Why?
|
Cell Hypoxia | 2 | 2015 | 662 | 0.290 |
Why?
|
Neovascularization, Physiologic | 4 | 2018 | 1369 | 0.280 |
Why?
|
Catheter Ablation | 2 | 2022 | 2780 | 0.280 |
Why?
|
Proteomics | 1 | 2021 | 3912 | 0.280 |
Why?
|
Osteoblasts | 1 | 2012 | 1145 | 0.270 |
Why?
|
Sleep | 2 | 2023 | 4819 | 0.270 |
Why?
|
NADP | 4 | 2009 | 229 | 0.270 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2008 | 446 | 0.270 |
Why?
|
Coronary Disease | 4 | 2021 | 5919 | 0.260 |
Why?
|
DNA Damage | 1 | 2016 | 2469 | 0.260 |
Why?
|
Rats | 15 | 2024 | 23760 | 0.250 |
Why?
|
Atherosclerosis | 3 | 2014 | 3433 | 0.250 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1133 | 0.250 |
Why?
|
Proto-Oncogene Proteins | 3 | 2019 | 4528 | 0.250 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1402 | 0.250 |
Why?
|
Myocardial Infarction | 6 | 2014 | 11519 | 0.250 |
Why?
|
Oxygenases | 1 | 2005 | 59 | 0.240 |
Why?
|
Ventricular Dysfunction | 1 | 2006 | 144 | 0.240 |
Why?
|
Cardiology | 1 | 2016 | 1702 | 0.240 |
Why?
|
Biomedical Research | 2 | 2021 | 3463 | 0.240 |
Why?
|
Cell Proliferation | 9 | 2020 | 10474 | 0.240 |
Why?
|
Atrial Fibrillation | 3 | 2022 | 5176 | 0.240 |
Why?
|
Coronary Thrombosis | 2 | 2005 | 440 | 0.240 |
Why?
|
Apoptosis | 7 | 2016 | 9523 | 0.240 |
Why?
|
Platelet Activation | 3 | 2010 | 644 | 0.230 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2014 | 1456 | 0.230 |
Why?
|
Gene Transfer Techniques | 4 | 2016 | 1207 | 0.230 |
Why?
|
Male | 52 | 2024 | 364719 | 0.220 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2006 | 2763 | 0.220 |
Why?
|
Nitro Compounds | 1 | 2003 | 74 | 0.220 |
Why?
|
Fibrinolytic Agents | 2 | 2008 | 2080 | 0.220 |
Why?
|
Tachyphylaxis | 1 | 2003 | 54 | 0.220 |
Why?
|
Complement Activation | 2 | 2020 | 447 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2019 | 2909 | 0.220 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2011 | 1169 | 0.210 |
Why?
|
Cattle | 6 | 2012 | 3819 | 0.210 |
Why?
|
Dexamethasone | 1 | 2010 | 1965 | 0.210 |
Why?
|
Fibrosis | 4 | 2020 | 2080 | 0.210 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2599 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 7 | 2020 | 8128 | 0.210 |
Why?
|
Early Diagnosis | 1 | 2008 | 1194 | 0.210 |
Why?
|
X-Rays | 1 | 2023 | 311 | 0.210 |
Why?
|
Aortic Valve | 1 | 2012 | 1970 | 0.200 |
Why?
|
Tissue Plasminogen Activator | 1 | 2008 | 1165 | 0.200 |
Why?
|
Wound Healing | 1 | 2013 | 2809 | 0.200 |
Why?
|
Treatment Outcome | 12 | 2023 | 65371 | 0.200 |
Why?
|
Pterins | 1 | 2001 | 11 | 0.190 |
Why?
|
Cyclic AMP | 3 | 2020 | 1470 | 0.190 |
Why?
|
Obesity | 2 | 2014 | 13090 | 0.190 |
Why?
|
Hydrodynamics | 2 | 2021 | 167 | 0.190 |
Why?
|
Pulmonary Edema | 1 | 2024 | 408 | 0.190 |
Why?
|
Angina, Unstable | 2 | 2006 | 893 | 0.180 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15454 | 0.180 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 671 | 0.180 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 627 | 0.180 |
Why?
|
Education | 2 | 2021 | 533 | 0.180 |
Why?
|
Nitric Oxide Synthase | 5 | 2009 | 911 | 0.180 |
Why?
|
Ticlopidine | 1 | 2005 | 730 | 0.170 |
Why?
|
Exercise Test | 5 | 2024 | 2186 | 0.170 |
Why?
|
Lymphokines | 1 | 2003 | 924 | 0.170 |
Why?
|
Glutathione | 7 | 2016 | 589 | 0.170 |
Why?
|
Female | 42 | 2024 | 397192 | 0.170 |
Why?
|
Aortic Valve Stenosis | 1 | 2012 | 2032 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2006 | 843 | 0.170 |
Why?
|
Second Messenger Systems | 1 | 2020 | 203 | 0.170 |
Why?
|
Scleroderma, Systemic | 1 | 2023 | 346 | 0.170 |
Why?
|
Periodicity | 1 | 2000 | 348 | 0.160 |
Why?
|
Random Allocation | 2 | 2014 | 2396 | 0.160 |
Why?
|
Hydrogen Peroxide | 3 | 2009 | 740 | 0.160 |
Why?
|
Endothelium | 2 | 2020 | 768 | 0.160 |
Why?
|
Middle Aged | 28 | 2024 | 223492 | 0.160 |
Why?
|
Stroke Volume | 3 | 2024 | 5622 | 0.160 |
Why?
|
Autistic Disorder | 1 | 2008 | 1240 | 0.150 |
Why?
|
Collagen Type III | 1 | 2018 | 92 | 0.150 |
Why?
|
Disease Models, Animal | 12 | 2020 | 18349 | 0.150 |
Why?
|
Forecasting | 2 | 2018 | 2945 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2018 | 163 | 0.150 |
Why?
|
Superoxides | 5 | 2012 | 389 | 0.150 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1656 | 0.140 |
Why?
|
Enzyme Inhibitors | 2 | 2006 | 3728 | 0.140 |
Why?
|
Glucose | 3 | 2016 | 4352 | 0.140 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 561 | 0.140 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2017 | 46 | 0.140 |
Why?
|
Hemorrhage | 2 | 2006 | 3467 | 0.140 |
Why?
|
Dependovirus | 2 | 2019 | 720 | 0.140 |
Why?
|
Organoselenium Compounds | 1 | 2016 | 21 | 0.140 |
Why?
|
Azoles | 1 | 2016 | 23 | 0.140 |
Why?
|
Down-Regulation | 3 | 2013 | 2937 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 2 | 2013 | 47 | 0.130 |
Why?
|
Folic Acid | 1 | 2003 | 1337 | 0.130 |
Why?
|
Dual-Specificity Phosphatases | 2 | 2013 | 71 | 0.130 |
Why?
|
Cyclic GMP | 5 | 2011 | 394 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 16045 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2013 | 9263 | 0.130 |
Why?
|
Nitrates | 1 | 1997 | 260 | 0.120 |
Why?
|
Diet | 1 | 2013 | 8089 | 0.120 |
Why?
|
Adenosine Monophosphate | 1 | 2016 | 232 | 0.120 |
Why?
|
Monitoring, Physiologic | 1 | 2023 | 1798 | 0.120 |
Why?
|
Aged | 24 | 2024 | 171504 | 0.120 |
Why?
|
Caveolin 1 | 1 | 2016 | 255 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 308 | 0.120 |
Why?
|
Brachial Artery | 1 | 2016 | 373 | 0.120 |
Why?
|
Renin-Angiotensin System | 2 | 2020 | 737 | 0.120 |
Why?
|
Heart Diseases | 1 | 2008 | 2819 | 0.120 |
Why?
|
Swine | 5 | 2017 | 5995 | 0.120 |
Why?
|
United States | 13 | 2024 | 73039 | 0.120 |
Why?
|
Endothelin-1 | 2 | 2015 | 296 | 0.120 |
Why?
|
Risk Factors | 13 | 2024 | 74944 | 0.120 |
Why?
|
Coronary Restenosis | 1 | 2017 | 396 | 0.120 |
Why?
|
Thrombophilia | 2 | 2009 | 308 | 0.110 |
Why?
|
Angina Pectoris | 1 | 2018 | 957 | 0.110 |
Why?
|
Heart Failure, Systolic | 1 | 2015 | 134 | 0.110 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 1232 | 0.110 |
Why?
|
Lipid Peroxidation | 3 | 2012 | 276 | 0.110 |
Why?
|
Pharmacogenetics | 1 | 2018 | 683 | 0.110 |
Why?
|
Graft Occlusion, Vascular | 1 | 2017 | 538 | 0.110 |
Why?
|
Myocardium | 3 | 2017 | 4788 | 0.110 |
Why?
|
Genetic Diseases, Inborn | 1 | 2018 | 606 | 0.110 |
Why?
|
Demography | 1 | 2018 | 1641 | 0.110 |
Why?
|
Aspirin | 1 | 2005 | 3135 | 0.110 |
Why?
|
Stents | 1 | 2005 | 3195 | 0.100 |
Why?
|
Peptides | 1 | 2005 | 4354 | 0.100 |
Why?
|
Ultrasonography | 2 | 2024 | 6004 | 0.100 |
Why?
|
Genetic Vectors | 2 | 2019 | 3402 | 0.100 |
Why?
|
Echocardiography | 4 | 2024 | 5047 | 0.100 |
Why?
|
Fibroblasts | 2 | 2020 | 4176 | 0.100 |
Why?
|
Sympathetic Nervous System | 1 | 2015 | 521 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.100 |
Why?
|
Postoperative Complications | 1 | 2014 | 15832 | 0.100 |
Why?
|
Pentosephosphates | 1 | 2011 | 6 | 0.100 |
Why?
|
Glucose-6-Phosphate | 1 | 2011 | 29 | 0.100 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2017 | 507 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 849 | 0.100 |
Why?
|
Myocardial Contraction | 3 | 2014 | 1525 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2018 | 10399 | 0.100 |
Why?
|
Hyperhomocysteinemia | 2 | 2003 | 118 | 0.090 |
Why?
|
Pilot Projects | 3 | 2015 | 8741 | 0.090 |
Why?
|
Myocytes, Cardiac | 2 | 2015 | 1681 | 0.090 |
Why?
|
Mice | 19 | 2020 | 82029 | 0.090 |
Why?
|
Catheterization | 1 | 2016 | 1430 | 0.090 |
Why?
|
Thrombolytic Therapy | 2 | 2001 | 2055 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4352 | 0.090 |
Why?
|
Time Factors | 7 | 2024 | 40218 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8054 | 0.090 |
Why?
|
Sulfhydryl Compounds | 1 | 2012 | 296 | 0.090 |
Why?
|
S-Nitrosothiols | 1 | 2010 | 35 | 0.090 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 937 | 0.090 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.090 |
Why?
|
Prognosis | 6 | 2024 | 30010 | 0.090 |
Why?
|
Cell Movement | 3 | 2020 | 5210 | 0.090 |
Why?
|
Models, Biological | 4 | 2020 | 9495 | 0.090 |
Why?
|
Constriction, Pathologic | 3 | 2020 | 1104 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4580 | 0.090 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2010 | 128 | 0.090 |
Why?
|
Drug Discovery | 1 | 2018 | 1068 | 0.090 |
Why?
|
Dehydroepiandrosterone | 2 | 2001 | 259 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2017 | 1424 | 0.080 |
Why?
|
Adult | 12 | 2024 | 223646 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1596 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3252 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1110 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20760 | 0.080 |
Why?
|
Angioplasty, Balloon | 1 | 2013 | 592 | 0.080 |
Why?
|
Life Style | 1 | 2021 | 3932 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2665 | 0.080 |
Why?
|
Oligonucleotides, Antisense | 2 | 2003 | 462 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2013 | 6316 | 0.080 |
Why?
|
Brachytherapy | 1 | 2017 | 1220 | 0.080 |
Why?
|
Drug Approval | 1 | 2016 | 821 | 0.080 |
Why?
|
Sex Distribution | 1 | 2014 | 2278 | 0.080 |
Why?
|
Blood Platelets | 2 | 2011 | 2479 | 0.080 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2012 | 481 | 0.080 |
Why?
|
Catalase | 2 | 2009 | 215 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2873 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 325 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2744 | 0.080 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2009 | 96 | 0.080 |
Why?
|
Mitochondria, Liver | 1 | 2009 | 190 | 0.080 |
Why?
|
Genotype | 3 | 2020 | 13045 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1904 | 0.070 |
Why?
|
Nitric Oxide Donors | 2 | 2009 | 126 | 0.070 |
Why?
|
alpha-Crystallin B Chain | 1 | 2007 | 24 | 0.070 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4568 | 0.070 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2011 | 486 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22379 | 0.070 |
Why?
|
Cysteine | 1 | 2012 | 897 | 0.070 |
Why?
|
Selenoproteins | 1 | 2009 | 216 | 0.070 |
Why?
|
NF-kappa B | 2 | 2013 | 2493 | 0.070 |
Why?
|
bcl-2-Associated X Protein | 2 | 2009 | 281 | 0.070 |
Why?
|
Inflammation | 3 | 2021 | 10873 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2062 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2013 | 3096 | 0.070 |
Why?
|
COS Cells | 1 | 2009 | 1135 | 0.070 |
Why?
|
Hemorrhagic Disorders | 1 | 2006 | 34 | 0.070 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2007 | 88 | 0.070 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 294 | 0.070 |
Why?
|
Alzheimer Disease | 1 | 2008 | 8759 | 0.070 |
Why?
|
Blotting, Western | 2 | 2010 | 5027 | 0.070 |
Why?
|
Endocrine System Diseases | 1 | 2008 | 250 | 0.070 |
Why?
|
Genetic Variation | 2 | 2018 | 6611 | 0.060 |
Why?
|
DNA Methylation | 1 | 2020 | 4428 | 0.060 |
Why?
|
Albuminuria | 1 | 2009 | 658 | 0.060 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2006 | 514 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10760 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13490 | 0.060 |
Why?
|
Blotting, Northern | 1 | 2007 | 1550 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.060 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2005 | 67 | 0.060 |
Why?
|
Tomography, Optical Coherence | 2 | 2017 | 2957 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15948 | 0.060 |
Why?
|
Stress, Mechanical | 2 | 2019 | 1676 | 0.060 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2005 | 117 | 0.060 |
Why?
|
Allopurinol | 1 | 2006 | 202 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1751 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1494 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1573 | 0.060 |
Why?
|
Premedication | 1 | 2005 | 246 | 0.060 |
Why?
|
Triazenes | 1 | 2003 | 8 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 858 | 0.060 |
Why?
|
Peroxynitrous Acid | 1 | 2003 | 40 | 0.060 |
Why?
|
Blood Pressure | 2 | 2017 | 8543 | 0.060 |
Why?
|
Mice, Knockout | 7 | 2020 | 14488 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2013 | 4283 | 0.060 |
Why?
|
Young Adult | 4 | 2021 | 60066 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1750 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2010 | 1613 | 0.050 |
Why?
|
Immunoblotting | 1 | 2007 | 1647 | 0.050 |
Why?
|
Complement C3 | 2 | 2020 | 434 | 0.050 |
Why?
|
Xanthine | 1 | 2003 | 11 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2018 | 59629 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 142 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2008 | 8542 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2016 | 12465 | 0.050 |
Why?
|
Arteriosclerosis | 3 | 2002 | 1055 | 0.050 |
Why?
|
Aging | 2 | 2020 | 8744 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2020 | 22291 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2011 | 693 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3706 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2016 | 3986 | 0.050 |
Why?
|
DNA Primers | 1 | 2007 | 2828 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2766 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 899 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2024 | 81762 | 0.050 |
Why?
|
Angiotensin II | 1 | 2005 | 843 | 0.050 |
Why?
|
Superoxide Dismutase | 1 | 2005 | 596 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4887 | 0.050 |
Why?
|
Nitroglycerin | 1 | 2003 | 332 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2219 | 0.050 |
Why?
|
Biological Availability | 1 | 2003 | 389 | 0.050 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2024 | 267 | 0.050 |
Why?
|
Mice, Mutant Strains | 4 | 2009 | 1754 | 0.050 |
Why?
|
Mutation | 4 | 2018 | 30238 | 0.050 |
Why?
|
Veterans | 1 | 2016 | 2669 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.050 |
Why?
|
Electrocardiography | 2 | 2008 | 6412 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9384 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 482 | 0.050 |
Why?
|
Pteridines | 1 | 2001 | 47 | 0.050 |
Why?
|
Glutathione Reductase | 1 | 2000 | 25 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2009 | 1388 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7454 | 0.050 |
Why?
|
Creatinine | 1 | 2006 | 1918 | 0.040 |
Why?
|
Tyrosine | 3 | 2016 | 1427 | 0.040 |
Why?
|
Shear Strength | 1 | 2021 | 160 | 0.040 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2000 | 96 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 2000 | 201 | 0.040 |
Why?
|
Glycolysis | 1 | 2024 | 837 | 0.040 |
Why?
|
Dinoprost | 2 | 2016 | 139 | 0.040 |
Why?
|
Membrane Potentials | 1 | 2003 | 1090 | 0.040 |
Why?
|
Secretory Pathway | 1 | 2020 | 53 | 0.040 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2004 | 483 | 0.040 |
Why?
|
Cell Line | 4 | 2010 | 15597 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12795 | 0.040 |
Why?
|
Complement Factor B | 1 | 2020 | 57 | 0.040 |
Why?
|
Cytosol | 1 | 2003 | 887 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5797 | 0.040 |
Why?
|
Liver | 2 | 2016 | 7577 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2006 | 1461 | 0.040 |
Why?
|
Blood Glucose | 2 | 2016 | 6430 | 0.040 |
Why?
|
Complement C5 | 1 | 2020 | 104 | 0.040 |
Why?
|
Pyrophosphatases | 1 | 2020 | 142 | 0.040 |
Why?
|
Blood Transfusion | 1 | 2006 | 1309 | 0.040 |
Why?
|
Complement Pathway, Alternative | 1 | 2020 | 113 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1793 | 0.040 |
Why?
|
Hospitalization | 2 | 2018 | 10840 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9615 | 0.040 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2020 | 205 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2021 | 297 | 0.040 |
Why?
|
5'-Nucleotidase | 1 | 2020 | 164 | 0.040 |
Why?
|
Cell Survival | 3 | 2016 | 5777 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2016 | 5889 | 0.040 |
Why?
|
Carbon Monoxide | 1 | 2022 | 560 | 0.040 |
Why?
|
Cohort Studies | 3 | 2024 | 41754 | 0.040 |
Why?
|
Exercise | 1 | 2015 | 5955 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6514 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6229 | 0.040 |
Why?
|
Women's Health | 1 | 2008 | 2082 | 0.040 |
Why?
|
Pulmonary Gas Exchange | 1 | 2020 | 389 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2007 | 2592 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 166 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6669 | 0.040 |
Why?
|
Survival Analysis | 2 | 2020 | 10101 | 0.040 |
Why?
|
Hemostasis | 2 | 2002 | 468 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2006 | 2227 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15869 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2003 | 711 | 0.040 |
Why?
|
Risk Assessment | 3 | 2024 | 24315 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 332 | 0.040 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 181 | 0.040 |
Why?
|
Parasympathomimetics | 1 | 2016 | 28 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7598 | 0.030 |
Why?
|
Rabbits | 1 | 2003 | 4772 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39348 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 478 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1406 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2011 | 1134 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2001 | 795 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4860 | 0.030 |
Why?
|
Survival Rate | 2 | 2024 | 12840 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2012 | 11669 | 0.030 |
Why?
|
Isoindoles | 1 | 2016 | 36 | 0.030 |
Why?
|
Aldehyde Reductase | 1 | 2016 | 70 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2020 | 855 | 0.030 |
Why?
|
Methacholine Chloride | 1 | 2016 | 220 | 0.030 |
Why?
|
Plethysmography | 1 | 2016 | 172 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1695 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 892 | 0.030 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
Primary Prevention | 1 | 2024 | 1188 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 103 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2005 | 3514 | 0.030 |
Why?
|
Resistin | 1 | 2016 | 172 | 0.030 |
Why?
|
Streptokinase | 1 | 1995 | 186 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4473 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 513 | 0.030 |
Why?
|
Lung Diseases, Interstitial | 1 | 2024 | 940 | 0.030 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2010 | 2298 | 0.030 |
Why?
|
Gene Knockdown Techniques | 2 | 2011 | 1606 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2006 | 2100 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 874 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 2016 | 574 | 0.030 |
Why?
|
Heart | 2 | 2022 | 4446 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20227 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2007 | 2056 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2006 | 2655 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1995 | 324 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 794 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2016 | 1377 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2011 | 3590 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18065 | 0.030 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2016 | 285 | 0.030 |
Why?
|
Forearm | 1 | 2016 | 427 | 0.030 |
Why?
|
Arteries | 1 | 2018 | 1127 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2536 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2016 | 293 | 0.030 |
Why?
|
Transfection | 1 | 2001 | 5755 | 0.030 |
Why?
|
Aerosols | 1 | 2016 | 634 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 812 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2004 | 2138 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2120 | 0.030 |
Why?
|
Protein Transport | 2 | 2012 | 1951 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2012 | 3428 | 0.030 |
Why?
|
Registries | 2 | 2006 | 8375 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 1836 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3814 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6329 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2003 | 2145 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 682 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4270 | 0.020 |
Why?
|
Angiography | 1 | 2017 | 1597 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26379 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 12168 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2014 | 591 | 0.020 |
Why?
|
Thiamine | 1 | 2012 | 160 | 0.020 |
Why?
|
Adolescent | 3 | 2016 | 89169 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 915 | 0.020 |
Why?
|
Bleeding Time | 1 | 2011 | 83 | 0.020 |
Why?
|
Length of Stay | 1 | 2005 | 6498 | 0.020 |
Why?
|
Pentose Phosphate Pathway | 1 | 2011 | 126 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2521 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2005 | 7876 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2011 | 378 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4978 | 0.020 |
Why?
|
I-kappa B Kinase | 1 | 2011 | 250 | 0.020 |
Why?
|
Mitochondria | 1 | 2003 | 3681 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2107 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2011 | 422 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2017 | 2125 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 474 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2011 | 432 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6526 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2012 | 563 | 0.020 |
Why?
|
Kidney Cortex | 1 | 2009 | 168 | 0.020 |
Why?
|
Lipogenesis | 1 | 2011 | 217 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54926 | 0.020 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 2009 | 23 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2011 | 231 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2892 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3623 | 0.020 |
Why?
|
Uncoupling Agents | 1 | 2009 | 46 | 0.020 |
Why?
|
Nitroso Compounds | 1 | 2009 | 71 | 0.020 |
Why?
|
Complement Membrane Attack Complex | 1 | 2009 | 105 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2016 | 873 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 210 | 0.020 |
Why?
|
Insulin | 2 | 2016 | 6607 | 0.020 |
Why?
|
Microvessels | 1 | 2013 | 585 | 0.020 |
Why?
|
Heterozygote | 2 | 2009 | 2798 | 0.020 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2009 | 262 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1523 | 0.020 |
Why?
|
Triglycerides | 1 | 2016 | 2464 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12543 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2016 | 12800 | 0.020 |
Why?
|
P-Selectin | 1 | 2011 | 598 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2457 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1673 | 0.020 |
Why?
|
Selenocysteine | 1 | 2009 | 127 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2011 | 769 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2981 | 0.020 |
Why?
|
Placenta | 1 | 2017 | 1725 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 874 | 0.020 |
Why?
|
Phosphorylation | 2 | 2011 | 8317 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2914 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1679 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4852 | 0.020 |
Why?
|
Sex Factors | 1 | 2001 | 10632 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1672 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2006 | 92 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 697 | 0.020 |
Why?
|
Calcification, Physiologic | 1 | 2006 | 170 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2009 | 899 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2012 | 1039 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9343 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13014 | 0.020 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 1986 | 179 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 12252 | 0.020 |
Why?
|
Homeostasis | 1 | 2016 | 3348 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5315 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2009 | 1207 | 0.010 |
Why?
|
Nitroprusside | 2 | 2000 | 272 | 0.010 |
Why?
|
Adenoviridae | 1 | 2009 | 1092 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1779 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2016 | 3329 | 0.010 |
Why?
|
Mortality | 1 | 2016 | 2911 | 0.010 |
Why?
|
Hepatocytes | 1 | 2011 | 1247 | 0.010 |
Why?
|
Metalloporphyrins | 1 | 2004 | 41 | 0.010 |
Why?
|
Ribose | 1 | 2004 | 63 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1972 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8890 | 0.010 |
Why?
|
Glycine | 1 | 2007 | 672 | 0.010 |
Why?
|
Arginine | 1 | 2007 | 932 | 0.010 |
Why?
|
Hindlimb | 1 | 2005 | 516 | 0.010 |
Why?
|
Hypertrophy | 1 | 2005 | 562 | 0.010 |
Why?
|
Recurrence | 1 | 1995 | 8509 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 2004 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 525 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2002 | 365 | 0.010 |
Why?
|
Cystathionine beta-Synthase | 1 | 2000 | 27 | 0.010 |
Why?
|
F2-Isoprostanes | 1 | 2000 | 35 | 0.010 |
Why?
|
Lipid Peroxides | 1 | 2000 | 74 | 0.010 |
Why?
|
Stroke | 1 | 2022 | 9755 | 0.010 |
Why?
|
Osteogenesis | 1 | 2006 | 1288 | 0.010 |
Why?
|
Acetylcholine | 1 | 2000 | 629 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7608 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26422 | 0.010 |
Why?
|
Ischemia | 1 | 2005 | 1900 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36743 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13671 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36535 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 30256 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9561 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42669 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2000 | 1209 | 0.010 |
Why?
|
Cell Membrane | 1 | 2003 | 3655 | 0.010 |
Why?
|
Proteins | 1 | 2007 | 6009 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1999 | 1145 | 0.010 |
Why?
|
Odds Ratio | 1 | 2003 | 9669 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2003 | 5349 | 0.000 |
Why?
|
Immunochemistry | 1 | 1986 | 116 | 0.000 |
Why?
|
Mesenteric Arteries | 1 | 1986 | 178 | 0.000 |
Why?
|
Histocytochemistry | 1 | 1986 | 699 | 0.000 |
Why?
|
Microspheres | 1 | 1986 | 788 | 0.000 |
Why?
|
Perfusion | 1 | 1986 | 1401 | 0.000 |
Why?
|
Cell Communication | 1 | 1986 | 1660 | 0.000 |
Why?
|